惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

N
News and Events Feed by Topic
S
Security @ Cisco Blogs
S
Secure Thoughts
Attack and Defense Labs
Attack and Defense Labs
cs.AI updates on arXiv.org
cs.AI updates on arXiv.org
Hacker News - Newest:
Hacker News - Newest: "LLM"
Recent Commits to openclaw:main
Recent Commits to openclaw:main
H
Hacker News: Front Page
博客园 - 叶小钗
H
Heimdal Security Blog
Microsoft Security Blog
Microsoft Security Blog
Forbes - Security
Forbes - Security
AI
AI
cs.CV updates on arXiv.org
cs.CV updates on arXiv.org
T
Troy Hunt's Blog
罗磊的独立博客
Application and Cybersecurity Blog
Application and Cybersecurity Blog
爱范儿
爱范儿
GbyAI
GbyAI
The Last Watchdog
The Last Watchdog
TaoSecurity Blog
TaoSecurity Blog
C
CXSECURITY Database RSS Feed - CXSecurity.com
D
DataBreaches.Net
Recent Announcements
Recent Announcements
Schneier on Security
Schneier on Security
C
Cisco Blogs
美团技术团队
D
Docker
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
WordPress大学
WordPress大学
月光博客
月光博客
雷峰网
雷峰网
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
H
Hackread – Cybersecurity News, Data Breaches, AI and More
A
Arctic Wolf
B
Blog RSS Feed
Cisco Talos Blog
Cisco Talos Blog
C
Cybersecurity and Infrastructure Security Agency CISA
V
Vulnerabilities – Threatpost
V2EX - 技术
V2EX - 技术
Y
Y Combinator Blog
N
News and Events Feed by Topic
www.infosecurity-magazine.com
www.infosecurity-magazine.com
W
WeLiveSecurity
Security Archives - TechRepublic
Security Archives - TechRepublic
G
GRAHAM CLULEY
Jina AI
Jina AI
Hugging Face - Blog
Hugging Face - Blog
酷 壳 – CoolShell
酷 壳 – CoolShell
The Hacker News
The Hacker News

Forbes - Healthcare

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses Centene Latest Health Insurer To Shakeup Management Ranks 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
What the 49ers Can Teach Leaders About Handling False And Misleading Narratives
Brian Castrucci · 2026-04-24 · via Forbes - Healthcare
Kansas City Chiefs v San Francisco 49ers

SANTA CLARA, CALIFORNIA - OCTOBER 20: Brandon Aiyuk #11 of the San Francisco reacts to an apparent injury during an NFL Football game against the Kansas City Chiefs at Levi's Stadium on October 20, 2024 in Santa Clara, California. (Photo by Michael Owens/Getty Images)

Getty Images

A torn ACL. A broken ankle. Injuries to groins, hamstrings, shoulders and more. In the last NFL season, the injuries piled up for the San Francisco 49ers.

Since 2017, the 49ers have led the league in games missed due to injuries, and fans and players wanted to know why.

Online, a theory emerged — and spread. The rash of injuries was not due to bad luck, poor conditioning or the realities of a violent sport. No, the theory was that the nearby power station was emitting radiation that could degrade collagen and make players more susceptible to injury.

Was it plausible? No. Did that stop it from spreading? No. Misinformation and conspiracy theories don’t need to be credible to be influential. They just need to be visible and repeated.

As the theory gained traction — with millions of social media shares, including some by 49ers players — the question for the team’s leadership was not “Could this be true?” It was “Can we afford to ignore it?” For General Manager John Lynch, the answer was no.

The team hired an independent scientist with 45 years of experience studying electromagnetic fields to take measurements throughout the facility.

The conclusion? Radiation levels in the stadium were 400 times lower than the threshold for an unsafe working environment. The level of exposure was less than a hair dryer or vacuum cleaner would produce.

But the lesson for business leaders is not about radiation levels. The investigation was not about validating the theory. It was about removing uncertainty inside and outside the organization.

Too often, organizations treat false narratives as a communications problem — something to either ignore or correct. But they affect more than reputation, seeping into decision-making environments, shaping perception and creating doubt where clarity is needed most.

And once doubt emerges inside the system, ignoring it doesn’t make it disappear. It gives it space to grow.

At the same time, overreacting — amplifying every fringe claim by responding to it — comes with its own risk. Attention can confer legitimacy, whether that’s the intent or not.

That’s the line leaders have to walk. If you engage too little, you allow misinformation to metastasize. If you engage too much, you elevate it.

The 49ers quietly and methodically contained it by testing the claim, answering the internal question and moving on. No spectacle. No prolonged debate. No attempt to win an argument online. They just released findings grounded in evidence.

That may sound obvious. But in many organizations, the instinct is to either dismiss implausible ideas outright or chase them publicly to disprove them. Both approaches miss the point.

The real challenge isn’t determining whether a claim is credible. It’s determining whether it has enough traction to affect how people think and act.

SANTA CLARA, CA - AUGUST 18: General manager John Lynch of the San Francisco 49ers stands on the sidelines prior to an NFL preseason football game against the New Orleans Saints, at Levi's Stadium on August 18, 2024 in Santa Clara, California. (Photo by Brooke Sutton/Getty Images)

Getty Images

In health care, false narratives about treatments influence patient decisions. In public health, rumors can shape behavior faster than official guidance. In corporate settings, speculation can affect employee confidence or investor sentiment.

In each case, the question isn’t whether misinformation exists. It always has. The question is how leaders respond once it enters their system.

The 49ers’ approach points to a useful framework:

  • Don’t ignore ideas that are influencing behavior, even if they’re implausible.
  • Don’t amplify them unnecessarily in the process of addressing them.
  • Use evidence to resolve internal uncertainty, not to attempt external persuasion.

That last point matters more than most people realize.

Science isn’t a communications strategy. It’s a decision-making tool.

It doesn’t stop false information from spreading. It doesn’t convince everyone. What it does — at its best — is establish a standard that organizations can rely on when it’s time to act.

In this case, that meant the 49ers could move forward without second-guessing the environment they were operating in.

No lingering doubts. No quiet speculation inside the locker room. No distraction from the work itself. Just clarity.

That’s the outcome leaders should be aiming for.

As the 2026 NFL Draft unfolds this week, every team is making bets on imperfect information. Some of those bets will be grounded in data. Others will be shaped by narratives that sound convincing but haven’t been tested.

Teams don’t lack information, but they sometimes mistake confidence for evidence.

The 49ers faced a version of that problem. Their response wasn’t to debate the narrative — it was to test it, resolve it and move forward.

Judgment calls can cost or save millions of dollars. That kind of discipline isn’t just good process — it’s a competitive advantage.